Vericel Corporation (VCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VCEL | AMGN | VRTX | REGN | GSK |
| Company | Vericel Corporation | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 48.33 | 306.42 | 451.90 | 984.04 | 45.42 |
| High | 48.33 | 307.39 | 455.00 | 988.77 | 45.45 |
| Low | 47.94 | 305.04 | 449.42 | 984.04 | 45.24 |
| Last | 48.02 | 305.58 | 455.77 | 985.39 | 45.32 |
| Change | +0.03 | -0.92 | +4.97 | +4.82 | +0.17 |
| % Change | +0.06% | -0.30% | +1.10% | +0.49% | +0.38% |
| Volume | 3,293 | 63,255 | 64,990 | 7,017 | 198,236 |
| 20-Day Average Volume | 362,400 | 2,750,066 | 1,111,667 | 412,436 | 3,830,752 |
| Previous Close | 47.99 | 306.50 | 450.80 | 980.57 | 45.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 48.38 | 303.28 | 424.42 | 961.50 | 44.28 |
| 20-Day Raw Stochastic | 38.08% | 70.43% | 99.47% | 90.43% | 84.79% |
| 20-Day Relative Strength | 49.88% | 58.37% | 73.58% | 60.37% | 62.89% |
| Weighted Alpha | +46.52 | +37.53 | +39.85 | +35.41 | +35.71 |
| Today's Opinion | 72% Buy | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 72% Buy | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 56% Buy | 72% Sell | 8% Buy | 8% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.86% since 05/17/24 | -1.83% since 05/17/24 | +2.12% since 05/17/24 | +0.47% since 05/17/24 | +0.58% since 05/17/24 |
| Low | 47.94 on 05/24/24 | 304.38 on 05/23/24 | 437.46 on 05/21/24 | 975.73 on 05/23/24 | 44.40 on 05/20/24 |
| High | 51.96 on 05/21/24 | 316.67 on 05/21/24 | 455.00 on 05/24/24 | 997.87 on 05/22/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | +3.96% since 04/24/24 | +12.36% since 04/24/24 | +13.45% since 04/24/24 | +8.86% since 04/24/24 | +10.72% since 04/24/24 |
| Low | 44.50 on 04/25/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 40.81 on 04/25/24 |
| High | 51.96 on 05/21/24 | 322.60 on 05/03/24 | 455.00 on 05/24/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +1.30% since 02/23/24 | +6.08% since 02/23/24 | +5.71% since 02/23/24 | +0.58% since 02/23/24 | +7.15% since 02/23/24 |
| Low | 42.38 on 04/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 53.05 on 04/01/24 | 322.60 on 05/03/24 | 455.00 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +34.42% since 11/24/23 | +15.55% since 11/24/23 | +28.79% since 11/24/23 | +23.63% since 11/24/23 | +26.33% since 11/24/23 |
| Low | 32.31 on 01/08/24 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.35 on 11/29/23 |
| High | 53.05 on 04/01/24 | 329.72 on 02/05/24 | 455.00 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,332,410 | 164,417,328 | 116,330,288 | 108,045,080 | 93,570,672 |
| Shares Outstanding, K | 48,602 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 197,520,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -3,180,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 51,280,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -3,860,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.74 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 05/08/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 29.72 | 26.51 | 11.33 |